Published in Am J Psychiatry on February 01, 2005
A retrospective analysis of cannabis use in a cohort of mentally ill patients in Sri Lanka and its implications on policy development. Subst Abuse Treat Prev Policy (2010) 0.78
Cannabis and schizophrenia spectrum disorders: a review of clinical studies. Indian J Psychol Med (2009) 0.76
Cannabis use and age at onset of schizophrenia. Am J Psychiatry (2004) 2.49
Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet (2011) 4.01
Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. N Engl J Med (2009) 3.88
Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am J Hum Genet (2010) 3.69
Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med (2008) 3.52
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci U S A (2010) 3.13
Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet (2011) 1.94
De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment. Am J Hum Genet (2010) 1.79
The role of the cerebellum in schizophrenia: an update of clinical, cognitive, and functional evidences. Schizophr Bull (2007) 1.38
De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism. Biol Psychiatry (2011) 1.25
Decrease of prefrontal metabolism after subthalamic stimulation in obsessive-compulsive disorder: a positron emission tomography study. Biol Psychiatry (2010) 1.17
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull (2014) 1.10
Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1. J Neurosci (2007) 1.10
Population-based and family-based association study of 5'UTR polymorphism of the reelin gene and schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2005) 1.05
Neurological soft-signs and minor physical anomalies in schizophrenia: differential transmission within families. Schizophr Res (2003) 1.04
Neurological soft signs in patients with schizophrenia and their unaffected siblings: frequency and correlates in two ethnic and socioeconomic distinct populations. Eur Arch Psychiatry Clin Neurosci (2009) 1.01
Minor physical anomalies in patients with schizophrenia and their parents: prevalence and pattern of craniofacial abnormalities. Psychiatry Res (2004) 1.01
Admixture analysis of age at onset in obsessive-compulsive disorder. Psychol Med (2005) 0.98
Long-term cognitive impairments induced by chronic cannabinoid exposure during adolescence in rats: a strain comparison. Psychopharmacology (Berl) (2012) 0.94
Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymorphisms in patients with obsessive compulsive disorder. Neuroreport (2004) 0.94
Polymorphisms TaqI A of the DRD2, BalI of the DRD3, exon III repeat of the DRD4, and 3' UTR VNTR of the DAT: association with childhood ADHD in male African-Caribbean cocaine dependents? Am J Med Genet B Neuropsychiatr Genet (2007) 0.89
The 5-HTTLPR polymorphism, impulsivity and suicide behavior in euthymic bipolar patients. J Affect Disord (2011) 0.88
Interaction of dopamine D1 with NMDA NR1 receptors in rat prefrontal cortex. Eur Neuropsychopharmacol (2009) 0.88
Cortex morphology in first-episode psychosis patients with neurological soft signs. Schizophr Bull (2012) 0.87
Effects of atypical neuroleptics on alertness and visual orienting in stabilized schizophrenic patients: a preliminary study. Int J Neuropsychopharmacol (2004) 0.87
CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis. Addict Biol (2011) 0.87
Specific pattern of attentional changes in impulsive individuals. Cogn Neuropsychiatry (2006) 0.86
Cognitive dysfunctions in medicated and unmedicated patients with recent-onset schizophrenia. J Psychiatr Res (2004) 0.86
Age at onset of schizophrenia: interaction between brain-derived neurotrophic factor and dopamine D3 receptor gene variants. Neuroreport (2005) 0.86
Neuronal activity correlated with checking behaviour in the subthalamic nucleus of patients with obsessive-compulsive disorder. Brain (2013) 0.85
Validity of the CAGE questionnaire in schizophrenic patients with alcohol abuse and dependence. Schizophr Res (2005) 0.85
A randomized, double-blind study comparing LY2216684 and placebo in the treatment of major depressive disorder. J Psychiatr Res (2011) 0.84
Association between the dopamine receptor D4 (DRD4) gene and obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet (2003) 0.83
Exposure to smoking cues during an emotion recognition task can modulate limbic fMRI activation in cigarette smokers. Addict Biol (2009) 0.82
Nicotine use in schizophrenia and disinhibition. Psychiatry Res (2004) 0.82
Altered semantic but not phonological verbal fluency in young help-seeking individuals with ultra high risk of psychosis. Schizophr Res (2010) 0.82
Behavioral perturbations after prenatal neurogenesis disturbance in female rat. Neurotox Res (2009) 0.82
Confirmation of the factorial structure of temperamental autoquestionnaire TEMPS-A in non-clinical young adults and relation to current state of anxiety, depression and to schizotypal traits. J Affect Disord (2011) 0.82
Neuropathological and Reelin deficiencies in the hippocampal formation of rats exposed to MAM; differences and similarities with schizophrenia. PLoS One (2010) 0.82
Clozapine-induced serositis: review of its clinical features, pathophysiology and management strategies. Clin Neuropharmacol (2009) 0.82
Real world referencing and schizophrenia: are we experiencing the same reality? Neuropsychologia (2010) 0.81
The role of BDNF genetic polymorphisms in bipolar disorder with psychiatric comorbidities. J Affect Disord (2010) 0.81
De novo truncating mutation in Kinesin 17 associated with schizophrenia. Biol Psychiatry (2010) 0.81
Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1: a new genetic model for Parkinson's disease? Parkinsonism Relat Disord (2008) 0.81
Polymorphisms of coding trinucleotide repeats of homeogenes in neurodevelopmental psychiatric disorders. Psychiatr Genet (2008) 0.81
Association study of the trinucleotide repeat polymorphism within SMARCA2 and schizophrenia. BMC Genet (2006) 0.81
Cognitive remediation therapy (CRT) benefits more to patients with schizophrenia with low initial memory performances. Disabil Rehabil (2014) 0.80
Factoring neurotrophins into a neurite-based pathophysiological model of schizophrenia. Prog Neurobiol (2011) 0.80
Exploring and visualizing multidimensional data in translational research platforms. Brief Bioinform (2016) 0.79
Don't be Too Strict with Yourself! Rigid Negative Self-Representation in Healthy Subjects Mimics the Neurocognitive Profile of Depression for Autobiographical Memory. Front Behav Neurosci (2013) 0.79
Correlation between clinical syndromes and neuropsychological tasks in unmedicated patients with recent onset schizophrenia. Psychiatry Res (2002) 0.79
Effect of antipsychotics on spontaneous hyperactivity and hypersensitivity to MK-801-induced hyperactivity in rats prenatally exposed to methylazoxymethanol. J Psychopharmacol (2010) 0.79
Impulsivity and sensation seeking in cannabis abusing patients with schizophrenia. Schizophr Res (2010) 0.79
Neurological soft signs in OCD patients with early age at onset, versus patients with schizophrenia and healthy subjects. J Neuropsychiatry Clin Neurosci (2011) 0.78
A step toward an objective quantification of subtle neurological signs in schizophrenia. Psychiatry Res (2012) 0.78
Attention and visual orienting in siblings, schizophrenic patients, and controls: impairment in attentional disengagement. J Clin Exp Neuropsychol (2009) 0.78
Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder. Curr Med Res Opin (2015) 0.78
Impaired saccadic adaptation in schizophrenic patients with high neurological soft sign scores. Psychiatry Res (2012) 0.78
Sensory dysfunction is correlated to cerebellar volume reduction in early schizophrenia. Schizophr Res (2007) 0.78
Correlates between neurological soft signs and saccadic parameters in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.78
Antidepressant treatment and smoking cessation in bipolar disorder. JAMA (2009) 0.78
Long-Term, Open-Label, Safety Study of Edivoxetine 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment. J Clin Psychopharmacol (2015) 0.78
Variable individual sensitivity to cannabis in patients with schizophrenia. Int J Neuropsychopharmacol (2010) 0.77
Diethylstilbestrol and risk of psychiatric disorders: a critical review and new insights. World J Biol Psychiatry (2011) 0.77
Alterations in prefrontal glutamatergic and noradrenergic systems following MK-801 administration in rats prenatally exposed to methylazoxymethanol at gestational day 17. Psychopharmacology (Berl) (2007) 0.77
Investigation of rare variants in LRP1, KPNA1, ALS2CL and ZNF480 genes in schizophrenia patients reflects genetic heterogeneity of the disease. Behav Brain Funct (2013) 0.77
Olanzapine for violent schizophrenia and Klinefelter syndrome. Am J Psychiatry (2002) 0.77
Impulsivity and sensation seeking in alcohol abusing patients with schizophrenia. Front Psychiatry (2010) 0.77
Military combat deployment and alcohol use. JAMA (2008) 0.77
Episodic memory and impairment of an early encoding process in schizophrenia. Neuropsychology (2010) 0.77
Association of inflammation genes with alcohol dependence/abuse: a systematic review and a meta-analysis. Eur Addict Res (2011) 0.77
Efficacy of varenicline for smoking cessation. JAMA (2006) 0.76
Inflexible information acquisition strategies mediate visuo-spatial reasoning in stabilized schizophrenia patients. World J Biol Psychiatry (2011) 0.76
Cerebellum development and schizophrenia: an association study of the human homeogene Engrailed 2. Psychiatry Res (2004) 0.76
Gender identity disorders and bipolar disorder associated with the ring Y chromosome. Am J Psychiatry (2007) 0.76
Hyperfrontality and hypoconnectivity during refreshing in schizophrenia. Psychiatry Res (2012) 0.76
Neurological soft signs in non-psychotic patients with cannabis dependence. Addict Biol (2010) 0.76
Predictive saccades are impaired in biological nonpsychotic siblings of schizophrenia patients. J Psychiatry Neurosci (2008) 0.76
Apolipoprotein E in schizophrenia: a French association study and meta-analysis. Am J Med Genet B Neuropsychiatr Genet (2003) 0.76
Mortality in patients with schizophrenia. Lancet (2009) 0.75
Efficacy outcomes from 3 clinical trials of edivoxetine as adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment. J Clin Psychiatry (2016) 0.75
Postnatal effect of embryonic neurogenesis disturbance on reelin level in organotypic cultures of rat hippocampus. Brain Res (2006) 0.75
Comparative efficacy of anti-manic drugs in acute mania. Lancet (2012) 0.75
[Early detection and early intervention in first episode psychosis]. Rev Prat (2013) 0.75
[Schizophrenic disorders: current etiologic and clinical knowledge]. Bull Acad Natl Med (2005) 0.75
Comparing effects of perceptual and reflective repetition on subjective experience during later recognition memory. Conscious Cogn (2007) 0.75
Ultra-resistant schizophrenia is not associated with the multidrug-resistant transporter 1 (MDR1) gene rs1045642 variant. J Clin Psychopharmacol (2011) 0.75
Creutzfeldt-Jakob disease presenting as psychosis. Am J Psychiatry (2004) 0.75
Potential application as screening and drug designing tools of cytoarchitectural deficiencies present in three animal models of schizophrenia. Expert Opin Drug Discov (2009) 0.75
Tobacco, alcohol and cannabis use in Tunisian patients with schizophrenia. Schizophr Res (2007) 0.75
Relationship between TSH levels in the normal range and short-term duloxetine efficacy. J Affect Disord (2009) 0.75
[Adaptation of a soft-signs scale to children with autism spectrum disorders]. Tunis Med (2009) 0.75
Torsade de Pointes associated with laxative abuse in a patient receiving methadone. J Neuropsychiatry Clin Neurosci (2013) 0.75
Olanzapine exposure during pregnancy. Aust N Z J Psychiatry (2007) 0.75
[Cannabis-induced cognitive and psychiatric disorders]. Bull Acad Natl Med (2015) 0.75
Clozapine and amisulpride in refractory schizophrenia and alcohol dependence. J Clin Psychopharmacol (2007) 0.75
[Principles of cognitive remediation in schizophrenia]. Bull Acad Natl Med (2011) 0.75
[Chromosomal integrity and schizophrenia]. Med Sci (Paris) (2009) 0.75